Literature DB >> 9240606

A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study.

P Garner1, N Okun, E Keely, G Wells, S Perkins, J Sylvain, J Belcher.   

Abstract

OBJECTIVES: The purpose of this study was to determine whether strict maternal glycemic control for the treatment of gestational diabetes lessened the risk of fetal macrosomia, birth trauma, neonatal hypoglycemia, and operative delivery. The aim of the pilot study was to prepare for a multicenter trial by assessing patient acceptance of the study, by determining realistic accrual rates, and by detecting any major adverse outcomes in the control group that received routine obstetric care. STUDY
DESIGN: The study was a prospective randomized controlled trial comparing fetal-neonatal and maternal outcomes in 300 women with gestational diabetes. Women randomized to the treatment arm were managed by strict glycemic control and tertiary level obstetric care, and women in the control arm received routine obstetric care.
RESULTS: Three hundred women with gestational diabetes mellitus were studied. There was no difference in maternal age, weight, or length of gestation between groups. The treatment mean birth weight was 3437 +/- 575 gm compared with 3544 +/- 601 gm in the control group, a difference of 107 gm (not significant). Macrosomia rates were similar. There was no birth trauma in either group. The frequency of neonatal hypoglycemia and other metabolic complications was the same. The mode of delivery also showed similar patterns. The treatment group had significantly lower preprandial and postprandial glucose levels by 32 weeks' gestation, which continued to term.
CONCLUSION: This pilot study suggests that intensive treatment of gestational diabetes mellitus may have little effect on birth weight, birth trauma, operative delivery, or neonatal metabolic disorders. It has demonstrated the safety of proceeding to a multicenter trial of sufficient sample size to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240606     DOI: 10.1016/s0002-9378(97)70461-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  31 in total

1.  Does screening for gestational diabetes mellitus make a difference?

Authors:  Mathew Sermer
Journal:  CMAJ       Date:  2003-02-18       Impact factor: 8.262

2.  Complications in neonates of mothers with gestational diabetes mellitus receiving insulin therapy versus dietary regimen.

Authors:  Zhaleh Fazel-Sarjoui; Amirali Khodayari Namin; Maryam Kamali; Nazanin Khodayari Namin; Ali Tajik
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-04

Review 3.  Lifestyle interventions for the treatment of women with gestational diabetes.

Authors:  Julie Brown; Nisreen A Alwan; Jane West; Stephen Brown; Christopher Jd McKinlay; Diane Farrar; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2017-05-04

4.  Risk perception and unrecognized type 2 diabetes in women with previous gestational diabetes mellitus.

Authors:  Janine Malcolm; Margaret L Lawson; Isabelle Gaboury; Erin Keely
Journal:  Obstet Med       Date:  2009-09-01

Review 5.  Intensive gestational glycemic management and childhood obesity: a systematic review and meta-analysis.

Authors:  L Guillemette; A Durksen; R Rabbani; R Zarychanski; A M Abou-Setta; T A Duhamel; J M McGavock; B Wicklow
Journal:  Int J Obes (Lond)       Date:  2017-03-13       Impact factor: 5.095

6.  Gestational diabetes mellitus: why screen and how to diagnose.

Authors:  T Karagiannis; E Bekiari; K Manolopoulos; K Paletas; A Tsapas
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

Review 7.  Third trimester glycemic profiles and fetal growth.

Authors:  Gustavo Leguizamón; Francisco von Stecher
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

Review 8.  Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis.

Authors:  Karl Horvath; Klaus Koch; Klaus Jeitler; Eva Matyas; Ralf Bender; Hilda Bastian; Stefan Lange; Andrea Siebenhofer
Journal:  BMJ       Date:  2010-04-01

Review 9.  What we have learned about the design of randomized trials in pregnancy.

Authors:  Elizabeth A Thom; Madeline Murguia Rice; George R Saade; Uma M Reddy
Journal:  Semin Perinatol       Date:  2016-06-22       Impact factor: 3.300

Review 10.  Insulin resistance: the possible link between gestational diabetes mellitus and hypertensive disorders of pregnancy.

Authors:  Dimitrios S Mastrogiannis; Michail Spiliopoulos; Wadia Mulla; Carol J Homko
Journal:  Curr Diab Rep       Date:  2009-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.